Susquehanna Fundamental Investments, LLC Dynavax Technologies Corp Transaction History

Susquehanna Fundamental Investments, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	SELL	$9.44 - $11.88 $996,023 - $1.25 Million	-105,511 Reduced 72.77%	39,472 $387,000
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $366,115 - $473,775	35,649 Added 32.61%	144,983 $1.54 Million
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $926,012 - $1.63 Million	93,254 Added 579.94%	109,334 $1.14 Million
Q1 2022 May 16, 2022	SELL	$9.75 - $14.44 $326,527 - $483,595	-33,490 Reduced 67.56%	16,080 $174,000
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $454,061 - $982,973	49,570 New	49,570 $952,000
Q2 2021 Aug 11, 2021	SELL	$7.25 - $10.99 $603,076 - $914,181	-83,183 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $380,146 - $929,985	83,183 New	83,183 $818,000
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $441,259 - $662,480	-118,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.32 - $11.7 $23,328 - $63,179	5,400 Added 4.78%	118,300 $511,000
Q2 2020 Aug 14, 2020	BUY	$2.94 - $9.1 $331,926 - $1.03 Million	112,900 New	112,900 $1 Million

275

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.61B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.